Compounds > pleconaril

pleconaril and efavirenz

pleconaril has been researched along with efavirenz in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (66.67)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Atzori, EM; Biava, M; Collu, G; Delogu, I; Desideri, N; Droghini, P; Fioravanti, R; Ibba, C; Loddo, R; Sanna, G1
Boido, V; Collu, G; Delogu, I; Giliberti, G; La Colla, P; Loddo, R; Novelli, F; Sparatore, A; Sparatore, F; Tasso, B; Tonelli, M1
Atzori, EM; Carta, A; Collu, G; Delogu, I; Desideri, N; Fioravanti, R; Loddo, R1
Briguglio, I; Carta, A; Carta, E; Corona, P; Fermeglia, M; Giliberti, G; Laurini, E; Loddo, R; Madeddu, S; Peana, AT; Piras, S; Pricl, S; Sanna, G; Serra, A; Vitale, G1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Berggren, PO; Juntti-Berggren, L; Klitz, W; Lindquist, L; Niklasson, B1

Other Studies

6 other study(ies) available for pleconaril and efavirenz

ArticleYear
N-((1,3-Diphenyl-1H-pyrazol-4-yl)methyl)anilines: A novel class of anti-RSV agents.
    Bioorganic & medicinal chemistry letters, 2015, Jun-01, Volume: 25, Issue:11

    Topics: Aniline Compounds; Antiviral Agents; Cell Line; Humans; Pyrazoles; Respiratory Syncytial Viruses; Virus Replication

2015
Antiviral activity of benzotriazole derivatives. 5-[4-(Benzotriazol-2-yl)phenoxy]-2,2-dimethylpentanoic acids potently and selectively inhibit Coxsackie Virus B5.
    Bioorganic & medicinal chemistry, 2015, Nov-01, Volume: 23, Issue:21

    Topics: Animals; Antiviral Agents; Cell Line; Cell Survival; Cricetinae; DNA Viruses; Dogs; Enterovirus B, Human; Humans; RNA Viruses; Structure-Activity Relationship; Triazoles; Virus Replication

2015
Inhibitors of Yellow Fever Virus replication based on 1,3,5-triphenyl-4,5-dihydropyrazole scaffold: Design, synthesis and antiviral evaluation.
    European journal of medicinal chemistry, 2017, Dec-01, Volume: 141

    Topics: Animals; Antiviral Agents; Cattle; Cell Line; Cell Survival; Cricetinae; Dose-Response Relationship, Drug; Drug Design; Haplorhini; Microbial Sensitivity Tests; Molecular Structure; Pyrazoles; Structure-Activity Relationship; Virus Replication; Yellow fever virus

2017
Quinoxaline derivatives as new inhibitors of coxsackievirus B5.
    European journal of medicinal chemistry, 2018, Feb-10, Volume: 145

    Topics: Animals; Antiviral Agents; Cattle; Cell Line; Cell Survival; Cricetinae; Dose-Response Relationship, Drug; Enterovirus B, Human; Haplorhini; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Quinoxalines; Structure-Activity Relationship

2018
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Effectiveness of Antivirals in a Type 1 Diabetes Model and the Move Toward Human Trials.
    Viral immunology, 2020, Volume: 33, Issue:9

    Topics: Adult; Alkynes; Animals; Antiviral Agents; Benzoxazines; Cyclopropanes; Diabetes Mellitus, Type 1; Humans; Male; Oxadiazoles; Oxazoles; Proof of Concept Study; Rats; Ribavirin

2020